← Eichor
Study identifier: NCT06983496 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Pharmacist-Intensivist Collaborative Telehealth for Post-Intensive Care Syndrome

Condition: Post Intensive Care Syndrome (PICS)  ·  Sponsor: Malcom Randall VA Medical Center

PhaseNA
Planned participants24
Who can joinAll sexes, 18 Years to 89 Years
Healthy volunteersNo

About this study

The goal of this pilot randomized controlled trial is to determine if a randomized controlled trial of a collaborative pharmacist-intensivist telehealth follow-up after intensive care unit discharge can feasibly be performed in patients who have survived a critical illness. The study intervention will be telehealth follow-up appointments provided by clinical pharmacists at approximately one and three months post-hospital discharge. The purpose of the follow-up appointments will be to assess for post-intensive care syndrome and provide recommend interventions aimed at improving recovery Participants will randomized to receive the study intervention or standard of care.

This description comes directly from the study's public registry record.

Talk to the study team

Andrew J Franck, Pharm.D.  ·  3523761611  ·  Andrew.Franck@va.gov

Always discuss trial participation with your own doctor first.

Locations (1)

Malcom Randall Veterans Affairs Medical CenterGainesville, Florida, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06983496